BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 80948)

  • 1. Cellular and humoral responses to myelin basic protein in multiple sclerosis: a dichotomy.
    Sheremata W; Woods DD; Moscarello MA
    Adv Exp Med Biol; 1978; 100():501-11. PubMed ID: 80948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of cellular sensitization to myelin antigens in multiple sclerosis. Dissociation of MIF and LBT production in response to a peptide encephalitogenic in rhesus monkeys.
    Colby-Germinario SP; Sheremata W; Bain B; Eylar EH
    J Neurol Sci; 1977 Aug; 33(1-2):111-29. PubMed ID: 71338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization to myelin basic protein in attacks of multiple sclerosis. A preliminary report.
    Sheremata W; Wood DD; Moscarello AA; Cosgrove JB
    J Neurol Sci; 1978 Apr; 36(2):165-70. PubMed ID: 206672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis: sensitization of a myelin basic protein fragment (peptide T) encephalitogenic to primates. A preliminary report.
    Sheremata W; Eylar EH; Cosgrove JB
    J Neurol Sci; 1977 Jun; 32(2):255-63. PubMed ID: 69018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis and cell-mediated hypersensitivity to myelin A1 protein.
    Sheremata W; Cosgrove JB; Eylar EH
    J Neurol Sci; 1976 Apr; 27(4):413-25. PubMed ID: 772176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular hypersensitivity to basic myelin (P2) protein in the Guillain-BarrĂ© syndrome.
    Sheremata W; Colby S; Karkhanis Y; Eylar EH
    Can J Neurol Sci; 1975 May; 2(2):87-90. PubMed ID: 165869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral factors in inflammatory disorders of the central and peripheral nervous system.
    Tindall RS
    J Neuroimmunol; 1988 Dec; 20(2-3):283-96. PubMed ID: 2848863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subacute sclerosing panencephalitis and multiple sclerosis: in vitro measles immunity and sensitization to myelin basic protein.
    Sheremata W; Sazant A; Watters G
    Can Med Assoc J; 1978 Mar; 118(5):509-13. PubMed ID: 343902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.
    Warren KG; Catz I
    Eur Neurol; 1999; 42(2):95-104. PubMed ID: 10473981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelin basic protein and multiple sclerosis.
    Whitaker JN
    Ital J Neurol Sci; 1983 Jun; 4(2):153-7. PubMed ID: 6194137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular hypersensitivity to gangliosides and myelin basic protein in multiple sclerosis.
    Ilyas AA; Davison AN
    J Neurol Sci; 1983 Apr; 59(1):85-95. PubMed ID: 6189970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated hypersensitivity in multiple sclerosis and other neurological diseases.
    Minderhoud JM; Mourik J; Teelken AW
    Clin Neurol Neurosurg; 1977; 80(1):22-32. PubMed ID: 73438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular hypersensitivity to basic myelin (A1) protein and clinical multiple sclerosis.
    Sheremata W; Cosgrove JB; Eylar EH
    N Engl J Med; 1974 Jul; 291(1):14-7. PubMed ID: 4598923
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct leukocyte migration inhibition by myelin basic protein in exacerbations of multiple sclerosis.
    Sheremata W; Triller H; Cosgrove JB; Eylar EH
    Can Med Assoc J; 1977 May; 116(9):985-8. PubMed ID: 870161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent lymphocyte cytotoxicity against basic protein of myelin in multiple sclerosis.
    Frick E; Stickl H
    J Neurol Sci; 1980 May; 46(2):187-97. PubMed ID: 6155446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
    Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
    Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoimmunosensor based on atomic force spectroscopy to detect anti-myelin basic protein related to early-stage multiple sclerosis.
    Garcia PS; Brum DG; Oliveira ON; Higa AM; Ierich JCM; Moraes AS; Shimizu FM; Okuda-Shinagawa NM; Peroni LA; da Gama PD; Machini MT; Leite FL
    Ultramicroscopy; 2020 Apr; 211():112946. PubMed ID: 32028099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
    Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
    Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of myelin basic protein-specific oligoclonal bands in multiple sclerosis.
    Morimoto K; Ikebe S; Sato T
    Ann N Y Acad Sci; 1988; 540():592-3. PubMed ID: 2462834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.